Factor VII heavy chain Polyclonal Antibody, PE-Cy7 Conjugated
Product Specifications
Background
Initiates the extrinsic pathway of blood coagulation. Serine protease that circulates in the blood in a zymogen form. Factor VII is converted to factor VIIa by factor Xa, factor XIIa, factor IXa, or thrombin by minor proteolysis. In the presence of tissue factor and calcium ions, factor VIIa then converts factor X to factor Xa by limited proteolysis. Factor VIIa will also convert factor IX to factor IXa in the presence of tissue factor and calcium.
Synonyms
SPCA; Coagulation factor VII; Proconvertin; Serum prothrombin conversion accelerator; F7
Gene ID
2155
Swiss Prot
P08709
Cellular Locus
Secreted
Host
Rabbit
Cross Reactivity
Human
Immunogen
301-400/466
Target
Factor VII heavy chain
Clonality
Polyclonal
Isotype
IgG
Conjugation
PE-Cy7
Source
KLH conjugated synthetic peptide derived from human Factor VII heavy chain
Applications
WB
Purification
Purified by Protein A.
Excitation Emission
488nm/780nm
Concentration
1µg/µl
Dilution
WB (1:300-5000)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Product Datasheet
https://www.biossantibodies.com/datasheets/bs-4846R-PE-Cy7
Gene ID URL
2155
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items